ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

APLT Applied Therapeutics Inc

4.67
0.17 (3.78%)
Fuera de horario
Última actualización: 15:30:23
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Applied Therapeutics Inc APLT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.17 3.78% 4.67 15:30:23
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.50 4.44 4.8491 4.67 4.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:25EDGAR2Form 8-K - Current report
05/6/202415:26EDGAR2Form 144 - Report of proposed sale of securities
04/6/202415:31EDGAR2Form 144 - Report of proposed sale of securities
17/5/202415:37EDGAR2Form 144 - Report of proposed sale of securities
16/5/202417:10EDGAR2Form 144 - Report of proposed sale of securities
09/5/202406:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202406:13EDGAR2Form 8-K - Current report
09/5/202406:00GLOBEApplied Therapeutics Reports First Quarter 2024 Financial..
07/5/202406:00GLOBEApplied Therapeutics to Present at the 2024 RBC Capital..
15/4/202406:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04/4/202406:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28/3/202415:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11/3/202407:17EDGAR2Form 8-K - Current report
06/3/202406:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202406:12EDGAR2Form 8-K - Current report
06/3/202406:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05/3/202416:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29/2/202415:18EDGAR2Form 8-K - Current report
28/2/202407:05GLOBEApplied Therapeutics Announces $100 Million Private..
28/2/202407:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22/2/202413:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202406:07EDGAR2Form 8-K - Current report
15/2/202406:00GLOBEApplied Therapeutics Announces Positive Results from..
14/2/202420:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202416:02EDGAR2Form 8-K - Current report
04/1/202415:05GLOBEApplied Therapeutics Announces Topline Results from the..
03/1/202410:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03/1/202408:15EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29/12/202315:23EDGAR2Form 8-K - Current report
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:11EDGAR2Form 8-K - Current report
13/11/202316:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202306:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:36EDGAR2Form 8-K - Current report
09/11/202306:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03/11/202315:37EDGAR2Form 144 - Report of proposed sale of securities
02/11/202315:33EDGAR2Form 144 - Report of proposed sale of securities
02/11/202306:00GLOBEApplied Therapeutics to Present at the UBS Biopharma..
01/11/202315:42EDGAR2Form 144 - Report of proposed sale of securities